-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
The company has been awarded the “AAA Credit Rating Enterprise in the Pharmaceutical Industry.”
Category:
发布时间：2019-12-20
【概要描述】
On December 20, the China Association of Chemical Pharmaceutical Industry, in collaboration with eight other national industry associations—including the China Association of Traditional Chinese Medicine—and 14 provincial and municipal pharmaceutical industry associations, including the Hebei Provincial Pharmaceutical Industry Association, successfully convened the First Joint Meeting of Industry Associations on Building a Credit System in the Medical and Pharmaceutical Sectors in Beijing. Shi Jianhui, Secretary of the Party Committee of the company, attended the meeting at the invitation of the organizers.
On December 20, the China Association for Pharmaceutical Industry, in collaboration with eight other national industry associations—including the China Association of Traditional Chinese Medicine—and 14 provincial and municipal pharmaceutical industry associations, including the Hebei Provincial Pharmaceutical Industry Association, successfully convened the First Joint Meeting of Industry Associations on Building a Credit System in the Medical and Pharmaceutical Sectors in Beijing. Shi Jianhui, Secretary of the Party Committee of the company, attended the meeting at the invitation of the organizers.
This conference is themed “Promoting Industry Self-Regulation and Upholding a Culture of Integrity,” with the primary mission of guiding member enterprises to “comply with laws, uphold credibility, and honor contracts.” Its overarching goal is to “enhance industry-wide credit management and foster a business environment characterized by honesty and trustworthiness,” thereby serving enterprises, the industry, the government, and society at large and ultimately driving high-quality development of the pharmaceutical sector.
At the meeting, the results of the 2019 pharmaceutical industry corporate credit rating were announced, with the company being awarded the “AAA Credit Rating” designation. According to available information, this evaluation was conducted from a neutral and impartial third-party perspective, based on a standardized assessment indicator system, employing scientific evaluation methods and adhering to rigorous evaluation procedures. Specifically, it involved the collection and analysis of credit-related information for all participating companies, followed by in-depth on-site inspections to gain a comprehensive understanding of each enterprise’s credit management practices. The final ratings were determined on the basis of the assessment reports issued by the independent credit service agency, after extensive consultation with industry experts.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091